Schwazze

Denver, United States Listed
Provider of cannabis dispensaries, cultivators, CPG brands, and services

About Schwazze

Schwazze is a publicly listed company based in Denver (United States). It operates as a provider of cannabis dispensaries, cultivators, CPG brands, and services. Schwazze has completed 4 acquisitions, including Emerald Fields, Mesa Organics and Reynold Greenleaf & Associates. Schwazze offers products and services including Cannabis Retail and Cannabis Cultivation. Its focus areas include Healthcare and Cannabis Services.

Company details

Operations in the cannabis industry are managed by Schwazze, encompassing retail dispensaries, cultivation activities, consumer packaged goods brands, and related services. The company is headquartered in Denver, United States, where focus is placed on integrated supply chain elements within the sector. Expansion efforts have been directed toward multi-state presence, supporting wholesale distribution and branded product development. Regulatory compliance is maintained across all functions.

  • Headquarters Denver, United States
  • Stage Public
  • Sectors
    Consumer
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website schwazze.com
  • Social LinkedIn X Facebook Instagram
  • Legal Name Medicine Man Technologies Inc.
Key Metrics
  • Annual Revenue
    $172.45 M (USD)
    8.2
    as on Dec 31, 2023
  • Net Profit
    -$34.55 M (USD)
    -87.08
    as on Dec 31, 2023
  • EBITDA
    $25.96 M (USD)
    -20.78
    as on Dec 31, 2023
  • Latest Funding Round
    $53.7M (USD), Post-IPO

    Mar 2021

  • Investors
  • Investments & Acquisitions

Products & Services of Schwazze

Schwazze offers a comprehensive portfolio of products and services, including Cannabis Retail and Cannabis Cultivation.

Cannabis Retail
Retail Services

Dispensaries and products are provided by Schwazze for recreational and medical use, including diverse strains and customer services in Colorado and New Mexico

Cannabis Cultivation
Agricultural Products

Cultivation and manufacturing services are offered by Schwazze, encompassing extracts, edibles, and vape products through its integrated operations

Funding Insights of Schwazze

  • Total Rounds 4
  • Last Round Post-IPO β€” $53.7M
  • First Round $1M

    (Sep 2017)

  • Investors Count 1

All 4 funding rounds of Schwazze with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2021$53.7MPost-IPO––
–
Jul 2019$21MPost-IPO––
Dec 2017$1.54MPost-IPO––
–
Sep 2017$1MPost-IPO––
–
Valuation history

1 investors in total: 1 institutional.

Investors in Schwazze

Schwazze has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Dye Capital & Company.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
-
–dyecapital.com-
Premium access

Investor details for Schwazze

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Schwazze

23 people are tracked at Schwazze (10 in leadership, 5 in board & advisors, 8 in team).

NameRoleGroup
Nirup Krishnamurthy
COOLeadership
Christine Jones
Chief Legal OfficerLeadership
Chris Driessen
Executive Vice President - Commercial SalesLeadership
Dan Pabon
General Counsel & Chief Government Affairs OfficerLeadership
Collin Lodge
VP of RetailLeadership
Austin Ronningen
Director, Procurement & Inventory ManagementLeadership
Justine Sanchez
Director Of Retail OperationsLeadership
Ken Bair
Executive Vice President Of RetailLeadership
Ian Morrissey
Director, Retail & Marketing TechnologyLeadership
Jim Biviano
Head Of MarketingLeadership
Pratap Mukharji
DirectorBoard & advisors
Salim Wahdan
DirectorBoard & advisors
Jeff Garwood
DirectorBoard & advisors
Brian Ruden
DirectorBoard & advisors
Jeff Cozad
DirectorBoard & advisors
Terry Adams
Business Analyst/it Project ManagerTeam
Sabrina L. Teixeira
Staff AccountantTeam
Christopher Cook
Accounting ManagerTeam
Nicholas Devincent
Cultivation Operations ManagerTeam
Bridget Bernhard
Senior Graphic DesignerTeam

3 more people are available in the full profile.

Premium access

Complete people profiles for Schwazze

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Schwazze

Schwazze is a publicly listed company on the OTC with ticker symbol SHWZ in USA, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date23 Mar 2022
  • Listed onNEO: SHWZ
  • Listed entityMedicine Man Technologies Inc.
  • Exchange sectorProcess industries
  • ISINUS58468U1060
  • Share price$0.00 (+900% on the day) · 2026-09-29
  • Market capitalisation$865.32
  • Volume (last session)588,805

Financials of Schwazze

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
2023$172.4M-$34.5M$26.0M
2022$159.4M-$18.5M$32.8M
2021$108.4M$14.5M$19.0M
2020$24.0M-$19.4M-$22.4M
Premium access

Detailed financial statements for Schwazze

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Schwazze

Schwazze has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Emerald Fields, Mesa Organics and Reynold Greenleaf & Associates.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Cannabis products are retailed for medical and recreational purposes.
urbandispensary.comDenver, United States2009Jun 2022β€’β€’β€’β€’
Medicinal cannabis is manufactured and produced for therapeutic uses.
reynoldgreenleaf.comAlbuquerque, United States2013Feb 2022β€’β€’β€’β€’
Limited information on core activities is available.
emeraldfields.comColorado Springs, United States2015Nov 2021$29M
Cannabis farms are owned and operated by Mesa Organics.
mesaorganics.comPueblo, United States2014Jun 2019β€’β€’β€’β€’
Premium access

Complete acquisition details for Schwazze

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Schwazze

7 dated milestones of Schwazze across 5 years, from founding to its latest funding, stage changes and deals.

  1. Funding First funding round of $1.0M.
  2. Acquisition Acquires Mesa Organics.
  3. Funding Latest funding round, Post-IPO, of $53.7M.
  4. Acquisition Acquires Emerald Fields.
  5. Acquisition Acquires Reynold Greenleaf & Associates.
  6. IPO Lists on the stock exchange (IPO).
  7. Acquisition Acquires Urban Dispensary.

Web traffic of Schwazze

The website of Schwazze (schwazze.com) receives about 2.8K visits a month.

  • Monthly visits
    2.8K

    ▲ 24.9% vs previous month

Top companies in Cannabis Platforms & Ecosystem Services

10 companies that operate in the same segment as Schwazze (Cannabis Platforms & Ecosystem Services), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Legal medical and recreational cannabis products are manufactured.
2016Ann Arbor, Michigan, United StatesUSD 89.95 M–214
Cannabis is cultivated, processed, and retailed by PharmaCann vertically.
2014Oak Park, Illinois, United StatesUSD 218.7 M–979
Consumer lawn and garden products and services are provided.
1868Columbus, Ohio, United States–USD 3.41 B5,300
Provider of cannabis based medical and consumer products
2016New York, New York, United StatesUSD 13.78 MUSD 17.42 M–
Offers medical & wellness cannabis products sourcing and processing services
2021London, England, United KingdomUSD 5.32 MUSD 258.08 K168
Cannabis extracts and white label solutions are provided globally.
2016United StatesUSD 13.56 M––
Cannabis products are produced, cultivated, branded, and processed.
2017New York, New York, United States––2,198
Developer of water-soluble cannabinoid extraction technologies
2018Los Alamos, New Mexico, United StatesUSD 47.59 M––
Medicinal cannabis is produced by Blueberries Medical in Colombia.
2013Bogota, Bogota, Colombia–USD 228.08 K–
Enzymatic bioconversions are designed for cannabinoid product synthesis.
2014Monrovia, California, United States––16
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Schwazze

Premium access

Complete news archive for Schwazze

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Schwazze

Schwazze is headquartered in Denver, United States. It is registered at Denver, Colorado, United States.

Annual revenue of Schwazze is $172.45M as on Dec 31, 2023.

Operations in the cannabis industry are managed by Schwazze, encompassing retail dispensaries, cultivation activities, consumer packaged goods brands, and related services. The company is headquartered in Denver, United States, where focus is placed on integrated supply chain elements within the sector. Expansion efforts have been directed toward multi-state presence, supporting wholesale distribution and branded product development. Regulatory compliance is maintained across all functions.

Schwazze offers Cannabis Retail and Cannabis Cultivation.

Yes, Schwazze is publicly traded on OTC under the ticker symbol SHWZ.

Schwazze has made 4 acquisitions, including Emerald Fields, Mesa Organics, and Reynold Greenleaf & Associates.

Schwazze has 1 investor. Key investors include Dye Capital & Company.

Schwazze operates through Schwazze.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available